Guidelines for Perioperative Antibacterial Prophylaxis in Urological Surgery | CMAC

Guidelines for Perioperative Antibacterial Prophylaxis in Urological Surgery

Clinical Microbiology and Antimicrobial Chemotherapy. 2000; 2(3):107-114

​ Naber K., Bergman B., Bishop M.C., Bjerklund Johansen T.E., Botto H., Lobel B., Cruz F.J., Selvaggi F.P.
antibacterial prophylaxis perioperative prophylaxis urology surgery
Section
Guidelines
Type
Journal article
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 2000; 2(3):107-114

Abstract

The present guidelines suggest preferable approaches to the problem of perioperative antibacterial prophylaxis in urological surgery. The following questions are discussed in detail: goals, timing, and duration of perioperative antibacterial prophylaxis, selection and route of administration of antibacterial agents. Recommendations for the different types of urological interventions are given. These guidelines are designed for urologists and clinical pharmacologists.

  • 1. Knopf H.J., Weib P., Schafer W., Funke P.-J. Nosocomial infections after transurethral prostatectomy. Eur Urol 1999; 36:207-12.
  • 2. Bruhl P., Plassmann D. Zur Wertbemessung der perioperativen antibiotischen Infektionsprophylaxe bei der transurethralen Prostatachirurgie. Infektionsverhutung in der Chirurgie, R. Haring. Berlin: Blackwell Wissenschaft; 1991.
  • 3. Hofstetter A. Urogenitale Infektionen. Berlin: Springer. Heidelberg. New York, etc; 1999.
  • 4. Bruns Т., Hochel S., Tauber R. Penoperative Antibiotikaprophylaxe in der operativen Urologie. Urologe В 1998; 38:269-72.
  • 5. Wilson N.I.L., Lewi H.J.E. Survey of antibiotic prophylaxis in British urological practice. Br J Urol 1985; 57:478-82.
  • 6. Glambek I. Antibiotikaprofylakse ved operasjoner pa prostata (Antibiotic prophylaxis in prostatic surgery). Tidsskr Nor Laegeforen 1982; 102: 1766-7.
  • 7. Hedelin H., Bergman В., Frimodt-Moller С., Grabe M., Nurmi M., Vaage S., Walter S. Antibiotikaprofylax vid diagnostiska och terapeutiska urologiska ingrepp. Nord Med 1995; 110: 9-11.
  • 8. Vogel F., Naber K.G., Wacha H., Shah P., Sorgel F., Kayser F.H., Maschmeyer G., Lode H. und eine Expertengruppe der Paul-Ehrlich-Gesellschaft fur Chemotherapie e.v. Parenterale Antibiotika bei Erwachsenen. Chemother J 1999; 8:3-56.
  • 9. Naber K.G., Hofstetter A.G., Bruhl P., Bichler K.H., Lebert C. Perioperative Prophylaxe bei Eingriffen an den Harnwegen und im mannlichen Genitalbereich (in print).
  • 10. Societe Francaise d'Anesethesie et de Reanimation (SFAR). Recommandations pour la pratique de 1'antibioprophylaxie en chirurgie. Actualisation. Pyrexie 1999; 3:21-30.
  • 11. Swedish-Norwegian Consensus Group. Antibiotic prophylaxis in surgery: Summary of a Swedish-Norwegian consensus conference. Scand J Infect Dis 1998; 30:547-57.
  • 12. Adam D., Daschner F. Infektionsverhutung bei operativen Eingriffen: Hygienemassnahmen und Antibiotikaprophylaxe. Stuttgart: Wissenschaftliche Verlags-Gesellschaft; 1993.
  • 13. Blumenberg E.A., Abrutyn E. Methods for reduction of urinary tract infection. Curr Opin Urol 1997; 7:47-51.
  • 14. Burke J.P., Garibaldi R.A., Britt M.R., et al. Prevention of catheter-associated urinary tract infections: Efficacy of daily meatal care regimes. Am J Med 1981; 70:655-8.
  • 15. Larsen E.H., Gasser T.C., Madsen P.O. Antibiotikaprophylaxe bei operativen Eingriffen in der Urologie. Extr Urol l989; 12:340-63.
  • 16. Naber K.G. Antibakterielle Chemoprophylaxe bei transurethraler Resektion der Prostata. Aktuel Urol 1987; 18:34-7.
  • 17. Hargreave T.B., Hindmarsh J.R., Eiton R., et al. Short term prophylaxis with cefotaxime for prostatic surgery. Br Med J 1982; 284:1008-10.
  • 18. Hargreave T.B., Botto H., Rikken G.H.J.M., Hindmarsh J.R., Mc Dermott T.E.D., Mjolnerod O.K., Petays P., Schalkhauser K., Stellos A. European collaborative study of antibiotic prophylaxis for transurethral resection of prostate. Eur Urology 1993; 23:437-43.
  • 19. DGKH: Empfehlungen der DGKH zur perioperativen Antibiotikapro-phylaxe. Hyg Med 1994; 19:213-22.
  • 20. Raz R., Almog D., Elhanan G., Shental J. The use of ceftriaxon in the prevention of urinary tract infection in patients undergoing transurethral resection of the prostate (TUR-P). Infection 1994; 22:347-9.
  • 21. Shearman C.P., Silverman S.H., Johnson M., Young C.H., Farrar D.J., Keighley M.R.B., Burdon D.W. Single dose, oral antibiotic cover for transurethral prostatectomy. Br J Urol 1988; 62:424-38.
  • 22. Del Rio G., Dalet F., Chechile G. Antimicrobial prophylaxis in urologic surgery: does it give some be-nefit? Eur Urol 1993; 24:305-11.
  • 23. Mangram A.J. Guidelines for prevention of surgical site infection. Am J Infect Control 1999; 27:1-55.
  • 24. Burke J.F. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery 1961; 50:161-8.
  • 25. Classen D.C. The timing of prophylactic administration of antibiotics and the risk of surgical wound infection. N Engl J Med 1992; 326:281-6.
  • 26. Miles A.A., Miles E.M., Burke J. The value and duration of defense reactions of the skin to the primary lodgement of bacteria. Br J Exp Pathol 1957; 38:79-96.
  • 27. Bergamini T.M., Polk H.C. The importance of tissue antibiotic activity in the prevention of operative wound infection. J Antimicrob Chemother 1989; 23:301-13.
  • 28. Bates Т., Siller G., Crathem B.C., Bradley S.P., Zlotnik R.D., Couch C., James R.D.G., Kaye C.M. Timing of prophylactic antibiotics in abdominal surgery: trial of a pre-operative versus an intraoperative first dose. Br J Surg 1989; 76:52-6.
  • 29. ASHP commission on therapeutics. ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery. Clin Pharm 1992; 11:483-513.
  • 30. Dellinger E.P., Gross P.A., et al. Quality standard for antimicrobial prophylaxis in surgical procedures. Infect Control Hosp Epidemiol 1994; 15:182-8.
  • 31. Mebust W.K., Holtgrewe H.L., Cockett A.T.K., Peters P.C., and Writing Committee. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3885 patients. J Urol 1989; 141:243-7.
  • 32. Baert L., Billiet I., Vandepitte J. Prophylactic chemotherapy with fosfomycin trometamol versus placebo during transurethral prostatic resection. Infection 1990; 18 (suppl. 2): 103-6.
  • 33. Periti P., Novelli A., Reali E.F., Del Bono G.P., Fontana P. Prophylactic chemotherapy with fosfomycin trometamol salt in transurethral prostatectomy. A controlled clinical trial. In: Neu H.C.,Williams J.D., editors. New trends in urinary tract infections. Basel: Karger; 1998. p. 207-33.
  • 34. Kapoor D.A., Klimberg I.W., Malek G.H., Wegenke J.D., Cox C.E., Pat.terson A.L., Graham E., Echols R.M., Whalen E., Kowalsky S.F. Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology 1998; 52:552-8.
  • 35. Haley R.W., Culver D.H., White J.W., et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985; 121:182-205.
  • 36. Pearle M.S., Roehrbom C.G. Antimicrobial prophylaxis prior to shock wave lithotripsy in patients with sterile urine before treatment: a meta-analysis and cost-effectiveness analysis. Urology 1997; 49:679-86.
  • 37. Cruse P.J.E., Foord R. The epidemiology of wound infection: A 10-year old prospective study of 62 939 wounds. Surg Clin North Am 1980; 60:27-40.
  • 38. Culver D.H., Horan T.C., Gaynes R.P., et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. Am J Med 1991; 91 (Suppl. 3B):152-7.
Views
0 Abstract
0 PDF
0 Crossref citations
Shared